New SIV Strain Found in Chimpanzee with AIDS Symptoms
Author Information
Author(s): Etienne Lucie, Nerrienet Eric, LeBreton Matthew, Bibila Godwin Tafon, Foupouapouognigni Yacouba, Rousset Dominique, Nana Ahmadou, Djoko Cyrille F, Tamoufe Ubald, Aghokeng Avelin F, Mpoudi-Ngole Eitel, Delaporte Eric, Peeters Martine, Wolfe Nathan D, Ayouba Ahidjo
Primary Institution: Institut de Recherche pour le Développement (IRD) and Université Montpellier 1
Hypothesis
How does SIV infection evolve in Central chimpanzees and what is its impact on their health?
Conclusion
The study reveals that SIVcpz can be pathogenic in Central chimpanzees, leading to clinical progression similar to AIDS in humans.
Supporting Evidence
- The chimpanzee showed a significant decline in CD4 counts over the study period.
- Viral load measurements indicated high levels of SIVcpz.
- The chimpanzee experienced multiple opportunistic infections.
- N-glycosylation site frequency in the virus increased significantly over time.
- The study provides the first clinical history of SIV infection in a Central chimpanzee.
Takeaway
Researchers found a sick chimpanzee with a new type of SIV that can make them very ill, just like HIV does to humans.
Methodology
The study involved clinical follow-up and biological analyses over 7 years, including viral load and CD4 count measurements.
Potential Biases
Potential bias due to the reliance on a single captive chimpanzee for longitudinal data.
Limitations
The study is based on a single case, limiting generalizability to the broader population of Central chimpanzees.
Participant Demographics
A male chimpanzee (Cam155), approximately 1.5 years old at the time of seizure.
Statistical Information
P-Value
p < 0.0001
Statistical Significance
p < 0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website